Perspective · 30 Nov 2024
Review articlePublished 30 Sep 2022
Covid-19 and Acute Respiratory Distress Syndrome (ARDS) a Clinical Review
Department of Microbiology, University of Hong Kong, Hong Kong
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The COVID-19 pandemic is a serious problem of the new era. Acute respiratory distress syndrome (ARDS) and respiratory failure are the major lung diseases in COVID-19 patients. Although a COVID-19 vaccine is now available, there is still an urgent need to find potential treatments to reduce the impact of her COVID-19 on already sick patients. Several experimental drugs have been approved by the FDA, but their efficacy and possible side effects are unknown. An increasing number of studies worldwide investigating potential COVID-19-related therapies may help identify effective ARDS treatments. This review article first provides an overview of the immunopathology of ARDS. He then outlines the management of his COVID-19 patient requiring intensive care unit (ICU), focusing on current treatment strategies being evaluated in clinical trials for patients with COVID-19-induced ARDS.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Respiratory Medicine.
Editorial · 30 Nov 2024
Respiratory Bronchioles: Structure, Function and Clinical Significance
Short communication · 30 Nov 2024
Homeopathic Remedies for Respiratory Conditions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Shuofeng Yuan”
